
David Lombard
Vice Chair of Clinical and Translational Research · University of Miami/Jackson Health System
Credentials: · · · ·
History
- Present
Clinical and Translational Research · University of Miami/Jackson Health System
- Present
Cancer Epigenetics Program · University of Miami/Jackson Health System
- Present
Cancer Epigenetics Research Program · University of Miami/Jackson Health System
- 1997–2001
- 1993–1997
1992: Harvard College
Research
SIRT3 regulates mitochondrial fatty-acid oxidation by reversible enzyme deacetylation
Nature · 2010 · 1,423 citations
Genomic instability and aging-like phenotype in the absence of mammalian SIRT6
Cell · 2006 · 1,304 citations
A role for the NAD-dependent deacetylase Sirt1 in the regulation of autophagy
Proceedings of the National Academy of Sciences of the United States of America · 2008 · 1,256 citations
- SF
4 papers
- RM
3 papers · 1 as a fellow

2 papers

2 papers · 2 as a fellow
- CK
2 papers

2 papers · 2 as a fellow

2 papers

2 papers · 2 as a resident
Grants
- 2025–2029
Epigenetic and Metabolic Mechanisms of Cadmium Cytotoxicity
Department of Veterans Affairs · I01
Contact PI · Miami Va Health Care System
- 2019–2029
The Sylvester Cancer Center Support Grant
National Cancer Institute · P30
Project lead · $99.4K · University of Miami School of Medicine
- 2022–2027
SIRT5 Inhibitors and Degraders as Novel Treatments for Ewing Sarcoma
National Cancer Institute · R01
Contact PI · $2.1M · University of Miami School of Medicine
- 2026–2027
Biological Acetylation in Health and Disease
National Cancer Institute · R13
Contact PI · $10K · Federation of Amer Soc for Exper Biology
Clinical trials
- 2026–2028


